Skip to content

Evaluation of safety and effectiveness regarding intraocular cyclophotocoagulation for refractory glaucoma

Evaluation of safety and effectiveness regarding intraocular cyclophotocoagulation for refractory glaucoma - Evaluation of safety and effectiveness regarding intraocular cyclophotocoagulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027090
Enrollment
20
Registered
2017-04-24
Start date
2017-04-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory terminal glaucoma Glaucoma absolutum

Interventions

By using endoscopic coaxial laser probe which is unapproved by this country, unapproved surgical technique will be conducted.

Sponsors

Sato Yuya Eye Clinic
Lead Sponsor
FiberTech Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)A case which intraocular pressure is not lowering sufficiently due to medication and multiple glaucoma surgery, and which intraocular pressure reduction by cyclophotocoagulation is most suitable. (2)A person who is older than 20 years old at the time of agreement, who can obtain consent on written paper, or who is able to obtain consent from one's person in parental authority in case the one is underage.

Exclusion criteria

Exclusion criteria: (1)A person who is not able to agree to participate in this study. (2)If principal investigator or a member of the research project determine inappropriate.

Design outcomes

Primary

MeasureTime frame
Postoperative reduction of intraocular pressure

Countries

Japan

Contacts

Public ContactHiroyuki Sato

Sato Yuya Eye Clinic Sato Yuya Eye Clinic

sato@chukyogroup.jp022-227-6752

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026